Skip to main navigation menu Skip to main content Skip to site footer

Review article: Biomedical intelligence

Vol. 148 No. 5152 (2018)

Chronic thromboembolic pulmonary hypertension

  • Isabelle Opitz
  • Silvia Ulrich
DOI
https://doi.org/10.4414/smw.2018.14702
Cite this as:
Swiss Med Wkly. 2018;148:w14702
Published
30.12.2018

Summary

Chronic thromboembolic pulmonary hypertension (CTEPH) is a potentially fatal disease, which may occur as a rare complication after acute pulmonary embolism, although the exact epidemiology of CTEPH is unknown. The mechanisms involved in nonresolution of thrombotic material and scarring of large and/or small pulmonary arteries are unknown; some risk factors have been identified. To date, CTEPH is still underdiagnosed and undertreated. The cardinal symptom of CTEPH is dyspnoea on exertion, but diagnosis is challenging owing to nonspecific symptoms. Right heart catheterisation is mandatory for the diagnosis of pulmonary hypertension, followed by several imaging methods including besides ventilation/perfusion scan, computed tomography pulmonary angiography and conventional angiography. Operability assessment by a multidisciplinary team is crucial for the management in all CTEPH patients, as pulmonary endarterectomy (PEA) remains the only curative treatment of choice. PEA leads to substantial improvement of haemodynamics, symptoms, and life expectancy enabling many patients to lead unrestricted lives under sole anticoagulation therapy. For inoperable patients or those with disease not amenable to surgery, medical therapy or balloon angioplasty are emerging treatment options. Owing to the complexity of CTEPH, the diagnosis and treatment of CTEPH patients is reserved exclusively to experienced CTEPH centres.

References

  1. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903–75. doi:.https://doi.org/10.1183/13993003.01032-2015
  2. Gall H, Hoeper MM, Richter MJ, Cacheris W, Hinzmann B, Mayer E. An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan. Eur Respir Rev. 2017;26(143):160121. doi:.https://doi.org/10.1183/16000617.0121-2016
  3. Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011;124(18):1973–81. doi:.https://doi.org/10.1161/CIRCULATIONAHA.110.015008
  4. Blauwet LA, Edwards WD, Tazelaar HD, McGregor CG. Surgical pathology of pulmonary thromboendarterectomy: a study of 54 cases from 1990 to 2001. Hum Pathol. 2003;34(12):1290–8. doi:.https://doi.org/10.1016/j.humpath.2003.07.003
  5. Bonderman D, Wilkens H, Wakounig S, Schäfers HJ, Jansa P, Lindner J, et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Re777spir J. 2009;33(2):325–31. doi:.https://doi.org/10.1183/09031936.00087608
  6. Karimi M, Cohan N. Cancer-associated thrombosis. Open Cardiovasc Med J. 2010;4:78–82.
  7. Simonneau G, Torbicki A, Dorfmüller P, Kim N. The pathophysiology of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017;26(143):160112. doi:.https://doi.org/10.1183/16000617.0112-2016
  8. Korkmaz A, Ozlu T, Ozsu S, Kazaz Z, Bulbul Y. Long-term outcomes in acute pulmonary thromboembolism: the incidence of chronic thromboembolic pulmonary hypertension and associated risk factors. Clin Appl Thromb Hemost. 2012;18(3):281–8. doi:.https://doi.org/10.1177/1076029611431956
  9. Otero R, Oribe M, Ballaz A, Jimenez D, Uresandi F, Nauffal D, et al. Echocardiographic assessment of pulmonary arterial pressure in the follow-up of patients with pulmonary embolism. Thromb Res. 2011;127(4):303–8. doi:.https://doi.org/10.1016/j.thromres.2010.12.010
  10. Poli D, Grifoni E, Antonucci E, Arcangeli C, Prisco D, Abbate R, et al. Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism. J Thromb Thrombolysis. 2010;30(3):294–9. doi:.https://doi.org/10.1007/s11239-010-0452-x
  11. Surie S, Gibson NS, Gerdes VE, Bouma BJ, van Eck-Smit BL, Buller HR, et al. Active search for chronic thromboembolic pulmonary hypertension does not appear indicated after acute pulmonary embolism. Thromb Res. 2010;125(5):e202–5. doi:.https://doi.org/10.1016/j.thromres.2009.12.016
  12. Dentali F, Donadini M, Gianni M, Bertolini A, Squizzato A, Venco A, et al. Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res. 2009;124(3):256–8. doi:.https://doi.org/10.1016/j.thromres.2009.01.003
  13. Martí D, Gómez V, Escobar C, Wagner C, Zamarro C, Sánchez D, et al. Incidencia de hipertensión pulmonar tromboembólica crónica sintomática y asintomática [Incidence of symptomatic and asymptomatic chronic thromboembolic pulmonary hypertension]. Arch Bronconeumol. 2010;46(12):628–33. Article in Spanish. doi:.https://doi.org/10.1016/S1579-2129(10)70137-3
  14. Klok FA, van Kralingen KW, van Dijk AP, Heyning FH, Vliegen HW, Huisman MV. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica. 2010;95(6):970–5. doi:.https://doi.org/10.3324/haematol.2009.018960
  15. Noble S, Pasi J. Epidemiology and pathophysiology of cancer-associated thrombosis. Br J Cancer. 2010;102(S1, Suppl 1):S2–9. doi:.https://doi.org/10.1038/sj.bjc.6605599
  16. Coquoz N, Weilenmann D, Stolz D, Popov V, Azzola A, Fellrath JM, et al. Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism. Eur Respir J. 2018;51(4):1702505. doi:.https://doi.org/10.1183/13993003.02505-2017
  17. Tiede H, Hoeper MM, Richter M, Cacheris W, Hinzmann B, Mayer E. Global burden of chronic thromboembolic pulmonary hypertension (CTEPH): An epidemiological analysis. Eur Respir J. 2014;44(Suppl 58).
  18. Lang IM, Dorfmüller P, Noordegraaf AV. The Pathobiology of Chronic Thromboembolic Pulmonary Hypertension. Ann Am Thorac Soc. 2016;13(Suppl 3):S215–21. doi:.https://doi.org/10.1513/AnnalsATS.201509-620AS
  19. Banks DA, Pretorius GV, Kerr KM, Manecke GR. Pulmonary endarterectomy: part I. Pathophysiology, clinical manifestations, and diagnostic evaluation of chronic thromboembolic pulmonary hypertension. Semin Cardiothorac Vasc Anesth. 2014;18(4):319–30. doi:.https://doi.org/10.1177/1089253214536621
  20. Ribeiro A, Lindmarker P, Johnsson H, Juhlin-Dannfelt A, Jorfeldt L. Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis. Circulation. 1999;99(10):1325–30. doi:.https://doi.org/10.1161/01.CIR.99.10.1325
  21. Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, et al.; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123(16):1788–830. doi:.https://doi.org/10.1161/CIR.0b013e318214914f
  22. McNeil K, Dunning J. Chronic thromboembolic pulmonary hypertension (CTEPH). Heart. 2007;93(9):1152–8. doi:.https://doi.org/10.1136/hrt.2004.053603
  23. Kim NH. Group 4 Pulmonary Hypertension: Chronic Thromboembolic Pulmonary Hypertension: Epidemiology, Pathophysiology, and Treatment. Cardiol Clin. 2016;34(3):435–41. doi:.https://doi.org/10.1016/j.ccl.2016.04.011
  24. Quarck R, Nawrot T, Meyns B, Delcroix M. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol. 2009;53(14):1211–8. doi:.https://doi.org/10.1016/j.jacc.2008.12.038
  25. Zabini D, Heinemann A, Foris V, Nagaraj C, Nierlich P, Bálint Z, et al. Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients. Eur Respir J. 2014;44(4):951–62. doi:.https://doi.org/10.1183/09031936.00145013
  26. Reesink HJ, Meijer RC, Lutter R, Boomsma F, Jansen HM, Kloek JJ, et al. Hemodynamic and clinical correlates of endothelin-1 in chronic thromboembolic pulmonary hypertension. Circ J. 2006;70(8):1058–63. doi:.https://doi.org/10.1253/circj.70.1058
  27. Bonderman D, Jakowitsch J, Redwan B, Bergmeister H, Renner MK, Panzenböck H, et al. Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol. 2008;28(4):678–84. doi:.https://doi.org/10.1161/ATVBAHA.107.156000
  28. Wolf M, Boyer-Neumann C, Parent F, Eschwege V, Jaillet H, Meyer D, et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J. 2000;15(2):395–9. doi:.https://doi.org/10.1034/j.1399-3003.2000.15b28.x
  29. Bonderman D, Turecek PL, Jakowitsch J, Weltermann A, Adlbrecht C, Schneider B, et al. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2003;90(3):372–6. doi:.https://doi.org/10.1160/TH03-02-0067
  30. Gu S, Su P, Yan J, Zhang X, An X, Gao J, et al. Comparison of gene expression profiles and related pathways in chronic thromboembolic pulmonary hypertension. Int J Mol Med. 2014;33(2):277–300. doi:.https://doi.org/10.3892/ijmm.2013.1582
  31. Morris TA, Marsh JJ, Chiles PG, Magaña MM, Liang NC, Soler X, et al. High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood. 2009;114(9):1929–36. doi:.https://doi.org/10.1182/blood-2009-03-208264
  32. Le Gal G, Delahousse B, Lacut K, Malaviolle V, Regina S, Blouch MT, et al.; Groupe d’Etudes sur la Thrombose des Hôpitaux Universitaires du Grand Ouest. Fibrinogen Aα-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism. Thromb Res. 2007;121(3):333–8. doi:.https://doi.org/10.1016/j.thromres.2007.05.003
  33. Suntharalingam J, Goldsmith K, van Marion V, Long L, Treacy CM, Dudbridge F, et al. Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur Respir J. 2008;31(4):736–41. doi:.https://doi.org/10.1183/09031936.00055107
  34. Marsh JJ, Chiles PG, Liang NC, Morris TA. Chronic thromboembolic pulmonary hypertension-associated dysfibrinogenemias exhibit disorganized fibrin structure. Thromb Res. 2013;132(6):729–34. doi:.https://doi.org/10.1016/j.thromres.2013.09.024
  35. Alias S, Redwan B, Panzenböck A, Winter MP, Schubert U, Voswinckel R, et al. Defective angiogenesis delays thrombus resolution: a potential pathogenetic mechanism underlying chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol. 2014;34(4):810–9. doi:.https://doi.org/10.1161/ATVBAHA.113.302991
  36. Frey MK, Alias S, Winter MP, Redwan B, Stübiger G, Panzenboeck A, et al. Splenectomy is modifying the vascular remodeling of thrombosis. J Am Heart Assoc. 2014;3(1):e000772. doi:.https://doi.org/10.1161/JAHA.113.000772
  37. Mayer E. Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2010;19(115):64–7. doi:.https://doi.org/10.1183/09059180.00007409
  38. Humbert M. Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology. Eur Respir Rev. 2010;19(115):59–63. doi:.https://doi.org/10.1183/09059180.00007309
  39. Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest. 1993;103(3):685–92. doi:.https://doi.org/10.1378/chest.103.3.685
  40. Bauer M, Wilkens H, Langer F, Schneider SO, Lausberg H, Schäfers HJ. Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension. Circulation. 2002;105(9):1034–6. doi:.https://doi.org/10.1161/hc0902.105719
  41. Mayer E, Jenkins D, Lindner J, D’Armini A, Kloek J, Meyns B, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011;141(3):702–10. doi:.https://doi.org/10.1016/j.jtcvs.2010.11.024
  42. Held M, Grün M, Holl R, Walter F, Schäfers HJ, Graeter T, et al. Chronisch thromboembolische pulmonale Hypertonie: Latenz bis zur Diagnosesicherung und klinischer Zustand bei Diagnosestellung [Chronic thromboembolic pulmonary hypertension: Time delay from onset of symtoms to diagnosis and clinical condition at diagnosis]. Dtsch Med Wochenschr. 2014;139(33):1647–52. Article in German.
  43. Gopalan D, Delcroix M, Held M. Diagnosis of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017;26(143):160108. doi:.https://doi.org/10.1183/16000617.0108-2016
  44. Fedullo P, Kerr KM, Kim NH, Auger WR. Chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2011;183(12):1605–13. doi:.https://doi.org/10.1164/rccm.201011-1854CI
  45. Armstrong I, Rochnia N, Harries C, Bundock S, Yorke J. The trajectory to diagnosis with pulmonary arterial hypertension: a qualitative study. BMJ Open. 2012;2(2):e000806. doi:.https://doi.org/10.1136/bmjopen-2011-000806
  46. Armstrong I, Harries C, Yorke J. The imPAHct survey: living with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2011;183:A6130.
  47. Al-Naamani K, Hijal T, Nguyen V, Andrew S, Nguyen T, Huynh T. Predictive values of the electrocardiogram in diagnosing pulmonary hypertension. Int J Cardiol. 2008;127(2):214–8. doi:.https://doi.org/10.1016/j.ijcard.2007.06.005
  48. Bonderman D, Wexberg P, Martischnig AM, Heinzl H, Lang MB, Sadushi R, et al. A noninvasive algorithm to exclude pre-capillary pulmonary hypertension. Eur Respir J. 2011;37(5):1096–103. doi:.https://doi.org/10.1183/09031936.00089610
  49. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol. 2003;41(6):1028–35. doi:.https://doi.org/10.1016/S0735-1097(02)02964-9
  50. Trip P, Nossent EJ, de Man FS, van den Berk IA, Boonstra A, Groepenhoff H, et al. Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses. Eur Respir J. 2013;42(6):1575–85. doi:.https://doi.org/10.1183/09031936.00184412
  51. Coghlan JG, Denton CP, Grünig E, Bonderman D, Distler O, Khanna D, et al.; DETECT study group. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis. 2014;73(7):1340–9. doi:.https://doi.org/10.1136/annrheumdis-2013-203301
  52. Hoeper MM, Pletz MW, Golpon H, Welte T. Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension. Eur Respir J. 2007;29(5):944–50. doi:.https://doi.org/10.1183/09031936.00134506
  53. Scheidl SJ, Englisch C, Kovacs G, Reichenberger F, Schulz R, Breithecker A, et al. Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients. Eur Respir J. 2012;39(1):119–24. doi:.https://doi.org/10.1183/09031936.00109710
  54. Held M, Meintz S, Baron S, Roth C, Wilkens H, Schäfers HJ, et al. Surgical cure of central sleep apnea? Am J Respir Crit Care Med. 2013;188(3):395–6. doi:.https://doi.org/10.1164/rccm.201210-1944IM
  55. Held M, Grün M, Holl R, Hübner G, Kaiser R, Karl S, et al. Cardiopulmonary exercise testing to detect chronic thromboembolic pulmonary hypertension in patients with normal echocardiography. Respiration. 2014;87(5):379–87. doi:.https://doi.org/10.1159/000358565
  56. Held M, Linke M, Jany B. Echokardiographie und Rechtsherzkatheterisierung bei pulmonaler Hypertonie [Echocardiography and right heart catheterization in pulmonal hypertension]. Dtsch Med Wochenschr. 2014;139(30):1511–7. Article in German.
  57. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, et al., Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033–73. doi:.https://doi.org/10.1093/eurheartj/ehu283
  58. Ruggiero A, Screaton NJ. Imaging of acute and chronic thromboembolic disease: state of the art. Clin Radiol. 2017;72(5):375–88. doi:.https://doi.org/10.1016/j.crad.2017.02.011
  59. Ley S, Ley-Zaporozhan J, Pitton MB, Schneider J, Wirth GM, Mayer E, et al. Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Eur Radiol. 2012;22(3):607–16. doi:.https://doi.org/10.1007/s00330-011-2290-4
  60. Reichelt A, Hoeper MM, Galanski M, Keberle M. Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography. Eur J Radiol. 2009;71(1):49–54. doi:.https://doi.org/10.1016/j.ejrad.2008.03.016
  61. Sugiura T, Tanabe N, Matsuura Y, Shigeta A, Kawata N, Jujo T, et al. Role of 320-slice CT imaging in the diagnostic workup of patients with chronic thromboembolic pulmonary hypertension. Chest. 2013;143(4):1070–7. doi:.https://doi.org/10.1378/chest.12-0407
  62. Thieme SF, Becker CR, Hacker M, Nikolaou K, Reiser MF, Johnson TR. Dual energy CT for the assessment of lung perfusion--correlation to scintigraphy. Eur J Radiol. 2008;68(3):369–74. doi:.https://doi.org/10.1016/j.ejrad.2008.07.031
  63. Thieme SF, Graute V, Nikolaou K, Maxien D, Reiser MF, Hacker M, et al. Dual Energy CT lung perfusion imaging--correlation with SPECT/CT. Eur J Radiol. 2012;81(2):360–5. doi:.https://doi.org/10.1016/j.ejrad.2010.11.037
  64. Dournes G, Verdier D, Montaudon M, Bullier E, Rivière A, Dromer C, et al. Dual-energy CT perfusion and angiography in chronic thromboembolic pulmonary hypertension: diagnostic accuracy and concordance with radionuclide scintigraphy. Eur Radiol. 2014;24(1):42–51. doi:.https://doi.org/10.1007/s00330-013-2975-y
  65. Renard B, Remy-Jardin M, Santangelo T, Faivre JB, Tacelli N, Remy J, et al. Dual-energy CT angiography of chronic thromboembolic disease: can it help recognize links between the severity of pulmonary arterial obstruction and perfusion defects? Eur J Radiol. 2011;79(3):467–72. doi:.https://doi.org/10.1016/j.ejrad.2010.04.018
  66. Ito K, Kubota K, Morooka M, Shida Y, Hasuo K, Endo H, et al. Diagnostic usefulness of 18F-FDG PET/CT in the differentiation of pulmonary artery sarcoma and pulmonary embolism. Ann Nucl Med. 2009;23(7):671–6. doi:.https://doi.org/10.1007/s12149-009-0292-y
  67. Hudson ER, Smith TP, McDermott VG, Newman GE, Suhocki PV, Payne CS, et al. Pulmonary angiography performed with iopamidol: complications in 1,434 patients. Radiology. 1996;198(1):61–5. doi:.https://doi.org/10.1148/radiology.198.1.8539407
  68. Stein PD, Athanasoulis C, Alavi A, Greenspan RH, Hales CA, Saltzman HA, et al. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation. 1992;85(2):462–8. doi:.https://doi.org/10.1161/01.CIR.85.2.462
  69. Kovacs G, Herve P, Barbera JA, Chaouat A, Chemla D, Condliffe R, et al. An official European Respiratory Society statement: pulmonary haemodynamics during exercise. Eur Respir J. 2017;50(5):1700578. doi:.https://doi.org/10.1183/13993003.00578-2017
  70. Jenkins D, Mayer E, Screaton N, Madani M. State-of-the-art chronic thromboembolic pulmonary hypertension diagnosis and management. Eur Respir Rev. 2012;21(123):32–9. doi:.https://doi.org/10.1183/09059180.00009211
  71. Berman M, Gopalan D, Sharples L, Screaton N, Maccan C, Sheares K, et al. Right ventricular reverse remodeling after pulmonary endarterectomy: magnetic resonance imaging and clinical and right heart catheterization assessment. Pulm Circ. 2014;4(1):36–44. doi:.https://doi.org/10.1086/674884
  72. Lewczuk J, Piszko P, Jagas J, Porada A, Sobkowicz B, Wrabec K, et al. Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest. 2001;119(3):818–23. doi:.https://doi.org/10.1378/chest.119.3.818
  73. Madani MM. Surgical Treatment of Chronic Thromboembolic Pulmonary Hypertension: Pulmonary Thromboendarterectomy. Methodist DeBakey Cardiovasc J. 2016;12(4):213–8. doi:.https://doi.org/10.14797/mdcj-12-4-213
  74. Kim NH, Delcroix M, Jenkins DP, Channick R, Dartevelle P, Jansa P, et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013;62(25, Suppl):D92–9. doi:.https://doi.org/10.1016/j.jacc.2013.10.024
  75. Jenkins D, Madani M, Fadel E, D’Armini AM, Mayer E. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017;26(143):160111. doi:.https://doi.org/10.1183/16000617.0111-2016
  76. Jenkins D. Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2015;24(136):263–71. doi:.https://doi.org/10.1183/16000617.00000815
  77. Madani MM, Auger WR, Pretorius V, Sakakibara N, Kerr KM, Kim NH, et al. Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2,700 patients. Ann Thorac Surg. 2012;94(1):97–103, discussion 103. doi:.https://doi.org/10.1016/j.athoracsur.2012.04.004
  78. Ng C, Jenkins DP. Surgical management of chronic thromboembolic pulmonary hypertension. Br J Hosp Med (Lond). 2013;74(1):31–5. doi:.https://doi.org/10.12968/hmed.2013.74.1.31
  79. Vuylsteke A, Sharples L, Charman G, Kneeshaw J, Tsui S, Dunning J, et al. Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial. Lancet. 2011;378(9800):1379–87. doi:.https://doi.org/10.1016/S0140-6736(11)61144-6
  80. Delcroix M, Lang I, Pepke-Zaba J, Jansa P, D’Armini AM, Snijder R, et al. Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry. Circulation. 2016;133(9):859–71. doi:.https://doi.org/10.1161/CIRCULATIONAHA.115.016522
  81. Opitz I, de Perrot M. Technique of Pulmonary Thromboendarterectomy. Oper Tech Thorac Cardiovasc Surg. 2012;17(3):168–80. doi:.https://doi.org/10.1053/j.optechstcvs.2012.07.004
  82. Jamieson SW, Kapelanski DP. Pulmonary endarterectomy. Curr Probl Surg. 2000;37(3):165–252. doi:.https://doi.org/10.1016/S0011-3840(00)80005-2
  83. Madani M, Jamieson SW. Pulmonary Endarterectomy for Chronic Thromboembolic Disease. Oper Tech Thorac Cardiovasc Surg. 2006;11(4):264–74. doi:.https://doi.org/10.1053/j.optechstcvs.2006.10.002
  84. Lindner J, Ambrož D, Novotný R, Nižňanský M, Šimková I, Boháčeková M, et al. Pulmonary endarterectomy combined with cardiac surgery: A 7-year retrospective analysis. Cor Vasa. 2015;57(2):e115–20. doi:.https://doi.org/10.1016/j.crvasa.2015.02.009
  85. Thistlethwaite PA, Auger WR, Madani MM, Pradhan S, Kapelanski DP, Jamieson SW. Pulmonary thromboendarterectomy combined with other cardiac operations: indications, surgical approach, and outcome. Ann Thorac Surg. 2001;72(1):13–7, discussion 17–9. doi:.https://doi.org/10.1016/S0003-4975(01)02686-8
  86. Raisinghani A, Ben-Yehuda O. Echocardiography in chronic thromboembolic pulmonary hypertension. Semin Thorac Cardiovasc Surg. 2006;18(3):230–5. doi:.https://doi.org/10.1053/j.semtcvs.2006.09.006
  87. Saouti N, de Man F, Westerhof N, Boonstra A, Twisk J, Postmus PE, et al. Predictors of mortality in inoperable chronic thromboembolic pulmonary hypertension. Respir Med. 2009;103(7):1013–9. doi:.https://doi.org/10.1016/j.rmed.2009.01.017
  88. Rahnavardi M, Yan TD, Cao C, Vallely MP, Bannon PG, Wilson MK. Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension : a systematic review. Ann Thorac Cardiovasc Surg. 2011;17(5):435–45. doi:.https://doi.org/10.5761/atcs.oa.10.01653
  89. Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008;177(10):1122–7. doi:.https://doi.org/10.1164/rccm.200712-1841OC
  90. Taboada D, Pepke-Zaba J, Jenkins DP, Berman M, Treacy CM, Cannon JE, et al. Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease. Eur Respir J. 2014;44(6):1635–45. doi:.https://doi.org/10.1183/09031936.00050114
  91. Cannon JE, Su L, Kiely DG, Page K, Toshner M, Swietlik E, et al. Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort. Circulation. 2016;133(18):1761–71. doi:.https://doi.org/10.1161/CIRCULATIONAHA.115.019470
  92. Hoeper MM, Madani MM, Nakanishi N, Meyer B, Cebotari S, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Lancet Respir Med. 2014;2(7):573–82. doi:.https://doi.org/10.1016/S2213-2600(14)70089-X
  93. Archibald CJ, Auger WR, Fedullo PF, Channick RN, Kerr KM, Jamieson SW, et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 1999;160(2):523–8. doi:.https://doi.org/10.1164/ajrccm.160.2.9808109
  94. Bonderman D, Skoro-Sajer N, Jakowitsch J, Adlbrecht C, Dunkler D, Taghavi S, et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation. 2007;115(16):2153–8. doi:.https://doi.org/10.1161/CIRCULATIONAHA.106.661041
  95. Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003;76(5):1457–62, discussion 1462–4. doi:.https://doi.org/10.1016/S0003-4975(03)00828-2
  96. Thistlethwaite PA, Madani MM, Kemp AD, Hartley M, Auger WR, Jamieson SW. Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes. Ann Thorac Surg. 2006;82(6):2139–45. doi:.https://doi.org/10.1016/j.athoracsur.2006.07.020
  97. Freed DH, Thomson BM, Berman M, Tsui SS, Dunning J, Sheares KK, et al. Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg. 2011;141(2):383–7. doi:.https://doi.org/10.1016/j.jtcvs.2009.12.056
  98. Ghofrani HA, D’Armini AM, Grimminger F, Hoeper MM, Jansa P, Kim NH, et al.; CHEST-1 Study Group. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013;369(4):319–29. doi:.https://doi.org/10.1056/NEJMoa1209657
  99. Simonneau G, D’Armini AM, Ghofrani HA, Grimminger F, Hoeper MM, Jansa P, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2). Eur Respir J. 2015;45(5):1293–302. doi:.https://doi.org/10.1183/09031936.00087114
  100. Simonneau G, D’Armini AM, Ghofrani HA, Grimminger F, Jansa P, Kim NH, et al. Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial. Lancet Respir Med. 2016;4(5):372–80. doi:.https://doi.org/10.1016/S2213-2600(16)30022-4
  101. Wiedenroth CB, Liebetrau C, Breithecker A, Guth S, Lautze HJ, Ortmann E, et al. Combined pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2016;35(5):591–6. doi:.https://doi.org/10.1016/j.healun.2015.10.030
  102. Collaud S, Brenot P, Mercier O, Fadel E. Rescue balloon pulmonary angioplasty for early failure of pulmonary endarterectomy: The earlier the better? Int J Cardiol. 2016;222:39–40. doi:.https://doi.org/10.1016/j.ijcard.2016.07.021
  103. Shimura N, Kataoka M, Inami T, Yanagisawa R, Ishiguro H, Kawakami T, et al. Additional percutaneous transluminal pulmonary angioplasty for residual or recurrent pulmonary hypertension after pulmonary endarterectomy. Int J Cardiol. 2015;183:138–42. doi:.https://doi.org/10.1016/j.ijcard.2015.01.034
  104. Federal Statistical Office S. Population of Switzlerland. last accessed 15.03.2018. https://www.bfs.admin.ch/bfs/de/home/statistiken/bevoelkerung.html.
  105. Feinstein JA, Goldhaber SZ, Lock JE, Ferndandes SM, Landzberg MJ. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation. 2001;103(1):10–3. doi:.https://doi.org/10.1161/01.CIR.103.1.10
  106. Sugimura K, Fukumoto Y, Satoh K, Nochioka K, Miura Y, Aoki T, et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J. 2012;76(2):485–8. doi:.https://doi.org/10.1253/circj.CJ-11-1217
  107. Kataoka M, Inami T, Hayashida K, Shimura N, Ishiguro H, Abe T, et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5(6):756–62. doi:.https://doi.org/10.1161/CIRCINTERVENTIONS.112.971390
  108. Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5(6):748–55. doi:.https://doi.org/10.1161/CIRCINTERVENTIONS.112.971077
  109. Mahmud E, Behnamfar O, Ang L, Patel MP, Poch D, Kim NH. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension. Interv Cardiol Clin. 2018;7(1):103–17. doi:.https://doi.org/10.1016/j.iccl.2017.09.003
  110. Andreassen AK, Ragnarsson A, Gude E, Geiran O, Andersen R. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart. 2013;99(19):1415–20. doi:.https://doi.org/10.1136/heartjnl-2012-303549
  111. Inami T, Kataoka M, Ando M, Fukuda K, Yoshino H, Satoh T. A new era of therapeutic strategies for chronic thromboembolic pulmonary hypertension by two different interventional therapies; pulmonary endarterectomy and percutaneous transluminal pulmonary angioplasty. PLoS One. 2014;9(4):e94587. doi:.https://doi.org/10.1371/journal.pone.0094587
  112. Inami T, Kataoka M, Yanagisawa R, Ishiguro H, Shimura N, Fukuda K, et al. Long-Term Outcomes After Percutaneous Transluminal Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension. Circulation. 2016;134(24):2030–2. doi:.https://doi.org/10.1161/CIRCULATIONAHA.116.024201
  113. Taniguchi Y, Miyagawa K, Nakayama K, Kinutani H, Shinke T, Okada K, et al. Balloon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension. EuroIntervention. 2014;10(4):518–25. doi:.https://doi.org/10.4244/EIJV10I4A89
  114. Olsson KM, Wiedenroth CB, Kamp JC, Breithecker A, Fuge J, Krombach GA, et al. Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience. Eur Respir J. 2017;49(6):1602409. doi:.https://doi.org/10.1183/13993003.02409-2016
  115. Ghofrani HA, Simonneau G, D’Armini AM, Fedullo P, Howard LS, Jaïs X, et al.; MERIT study investigators. Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study. Lancet Respir Med. 2017;5(10):785–94. doi:.https://doi.org/10.1016/S2213-2600(17)30305-3
  116. Jaïs X, D’Armini AM, Jansa P, Torbicki A, Delcroix M, Ghofrani HA, et al.; Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension Study Group. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol. 2008;52(25):2127–34. doi:.https://doi.org/10.1016/j.jacc.2008.08.059
  117. Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, et al., EINSTEIN Investigators. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363(26):2499–510. doi:.https://doi.org/10.1056/NEJMoa1007903
  118. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, et al.; Authors/Task Force Members. Corrigendum to: 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2015;36(39):2642. doi:.https://doi.org/10.1093/eurheartj/ehu479

Most read articles by the same author(s)